Who Is Really at Risk for Anaphylaxis Due to COVID-19 Vaccine?
The vaccination campaign against the Severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2) started on 8 December 2020 in UK, after the approval of BNT162b2 by the Healthcare products Regulatory Agency (MHRA) [...]
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI AG
2021-01-01
|
| coleção: | Vaccines |
| Assuntos: | |
| Acesso em linha: | https://www.mdpi.com/2076-393X/9/1/38 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|